PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has extended its supply agreement with Ferring Pharmaceuticals, Inc. for the sale of its needle-free drug vial adapters. The new agreement extends the most recent agreement for an additional three years with two consecutive one year renewal options.
